5 Pharmaceutical Stocks to Buy According to Lawrence Hawkins’ Prosight Capital

Page 5 of 5

1. Prothena Corporation plc (NASDAQ:PRTA)

Prosight Capital Stake Value: $21.7 million

Percentage of Prosight Capital’s 13F Portfolio: 13.56%

No. of Hedge Fund Holders: 20

Ranked first on the list of 10 pharmaceutical stocks to buy according to Lawrence Hawkins’ Prosight Capital is Prothena Corporation plc (NASDAQ:PRTA). It is a late-stage clinical firm located in Ireland. The company’s research and development efforts are focused on the discovery and development of new antibodies for the treatment of a variety of disorders involving protein misfolding and cell adhesion.

Hawkins’ Prosight Capital owns 422,000 shares worth $21.7 million in Prothena Corporation plc (NASDAQ:PRTA), which makes up 13.56% of Hawkins’ 13F portfolio.

On September 30, RBC Capital analyst Kennen MacKay kept an Outperform rating on Prothena Corporation plc (NASDAQ:PRTA) stock with an increase in price target to $82 from $59.

You can also take a peek at the 10 Stocks to Sell According to Julian Robertson’s Tiger Management and Daniel Patrick Gibson’s Sylebra Capital Management is Buying AMD and 9 Other Stocks.

Page 5 of 5